Keywords: biovail, gets, approval, long-acting, cardizem, la, launch

Biovail gets US approval for long-acting Cardizem LA; launch in April

Article | 17 February 2003

Print This

Canada's Biovail has achieved a significant milestone with the USapproval of Cardizem LA (diltiazem), the first drug developed under a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in